CARBOPLATIN

作品数:69被引量:120H指数:6
导出分析报告
相关领域:医药卫生更多>>
相关作者:马建郑梅迟玉芬李明高键更多>>
相关机构:日照市人民医院佳木斯医学院附属医院浙江省医学科学院吉林大学第一医院更多>>
相关期刊:更多>>
相关基金:国家自然科学基金国家重点基础研究发展计划国家高技术研究发展计划吉林省科技厅青年科研基金更多>>
-

检索结果分析

结果分析中...
条 记 录,以下是1-10
视图:
排序:
Carboplatin restores neuronal toxicity in FUS-linked amyotrophic lateral sclerosis
《Neural Regeneration Research》2025年第8期2319-2320,共2页Kiyoung Kim 
supported by the BK21 FOUR(Fostering Outstanding Universities for Research);the Basic Science Research Program through the National Research Foundation of Korea(NRF);the Regional Innovation Mega Project Program through the Korea Innovation Foundation funded by the Ministry of Education(MOE);the Ministry of Science and ICT(MSIT)(NRF-2022R1A2C1004204,RS-2023-00219563,2023-DD-UP-0007);the Soonchunhyang University Research Fund(to KK)。
Amyotrophic lateral sclerosis(ALS),also known as Lou Geh rig's disease,is a progressive neurodegenerative disorder that affects motor neurons in the brain and spinal cord.This leads to muscle weakness,paralysis,and ul...
关键词:PARALYSIS SCLEROSIS RESPIRATORY 
Comparison of irinotecan/carboplatin versus etoposide/carboplatin for extended disease small cell lung cancer(ED-SCLC):A systematic review and meta-analysis of randomized controlled trials
《Malignancy Spectrum》2024年第4期300-311,共12页Zeeshan Afzal Sara Hira Xia Song Na Wang 
Background:Platinum-based chemotherapy in addition to the nonplatinum agent etoposide is the standard of care for extensive-stage small cell lung cancer(ES-SCLC).However,the front-line chemotherapy regimen is not know...
关键词:CARBOPLATIN ED-SCLC ETOPOSIDE IRINOTECAN small cell lung cancer 
Efficacy and safety of paclitaxel liposome versus paclitaxel in combination with carboplatin in the first-line chemotherapy for ovarian cancer:a multicenter,open-label,non-inferiority,randomized controlled trial
《Journal of the National Cancer Center》2024年第2期135-141,共7页Rong Li Hongping Zhang Qingshui Li Guangwen Yuan Yanjie Zhou Rutie Yin He Wang Chunyan Wang Yi Huang Wei Wang Xiaojian Yan Lingying Wu Qi Zhou 
funded by the Optimization Study of Treatment Regimen and Clinical Practice in Ovarian Cancer(grant number:2016YFC1303702).
Background:The paclitaxel liposome formulation,encapsulating paclitaxel within a phospholipid bilayer,ad-dresses the insolubility of traditional paclitaxel formulations,thereby reducing toxicity without compromising i...
关键词:Ovarian cancer Paclitaxel liposome First-line chemotherapy Efficacy Safety 
Chemical degradation of platinum oncolytics in urine and speciation of the inorganic contaminants cisplatin and carboplatin relevant in waste water
《Emerging Contaminants》2024年第1期47-53,共7页Karel Folens Janis Baeten Karen Couvreur Gijs Du Laing 
Understanding the prevalent form of platinum(Pt)based antineoplastic agents,used in chemotherapy,is of importance to develop a remediation strategy that restricts aquatic exposure.The speciation of Pt-based compounds ...
关键词:Pharmaceuticals Inorganic contaminants Speciation analysis ECOTOXICITY 
Diagnostic challenges and individualized treatment of cervical adenocarcinoma metastases to the breast:A case report被引量:1
《World Journal of Clinical Cases》2024年第2期412-417,共6页Allison Akers Susan Read John Feldman Casey Gooden Diana P English 
BACKGROUND Cervical cancer is a rare primary tumor resulting in metastases to the breast with few cases reported in literature.Breast metastases are associated with poor prognosis.The following case highlights the dia...
关键词:Cervical adenocarcinoma Breast metastases IMMUNOTHERAPY Pembrolizumab CARBOPLATIN PACLITAXEL Case report 
Envafolimab combined with chemotherapy in the treatment of combined small cell lung cancer: A case report被引量:1
《World Journal of Clinical Cases》2023年第5期1115-1121,共7页Mei-Hong Liu Yan-Xia Li Zhuo Liu 
Supported by the Foundation of Science and Technology Bureau of Dalian,No. 2021JJ13SN70。
BACKGROUND Combined small cell lung cancer(C-SCLC) is a special subtype of small cell lung cancer that is relatively rare, aggressive, and prone to early metastasis and has a poor prognosis. Currently, there are limit...
关键词:Combined small cell lung cancer Envafolimab CARBOPLATIN ETOPOSIDE PROGNOSIS Case report 
COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer
《Acta Biochimica et Biophysica Sinica》2023年第1期34-42,共9页Zhiyang Zhou Li Jin Jian Shen Weihui Shi Yue Xu Longyun Ye Junxi Liu Jiexue Pan 
This work was supported by the grant from the National Natural Science Foundation of China(No.21672225).
Despite favorable responses to platinum-based chemotherapy in ovarian cancer(OC),chemoresistance is still a major cause of treatment failure.Hence,we develop a novel synthetic agent,COM33,to relieve the chemoresistanc...
关键词:COM33 CARBOPLATIN ovarian cancer epithelial-mesenchymal transition TWIST1 
Mechanisms of chemotherapy resistance in ovarian cancer被引量:8
《Cancer Drug Resistance》2022年第2期304-316,共13页Mylena Ortiz Emma Wabel Kerry Mitchell Sachi Horibata 
Ovarian cancer is one of the most lethal gynecologic cancers.The standard therapy for ovarian cancer has been the same for the past two decades,a combination treatment of platinum with paclitaxel.Recently,the FDA appr...
关键词:Drug resistance ovarian cancer CISPLATIN CARBOPLATIN PACLITAXEL OLAPARIB niraparib BEVACIZUMAB 
Anaphylaxis to Cisplatin after Carboplatin Hypersensitivity Reaction in Advanced Non-Small Cell Lung Cancer
《Case Reports in Clinical Medicine》2021年第10期295-302,共8页Chau Thi Ngoc Dieu Gia Hoang Nguyen Quynh Thi Hong Mai 
Patients with non-small cell lung cancer (NSCLC) who have received more than one cycle of platinum-based chemotherapy in their lifetime may be at risk of hypersensitivity. The overall incidence of hypersensitivity to ...
关键词:Non-Small Cell Lung Cancer ANAPHYLAXIS CISPLATIN CARBOPLATIN HYPERSENSITIVITY 
Gas-blasting nanocapsules to accelerate carboplatin lysosome release and nucleus delivery for prostate cancer treatment被引量:1
《Asian Journal of Pharmaceutical Sciences》2021年第2期192-202,共11页Shunli Fu Shuang Liang Dandan Jiang Rui Yang Zipeng Zhang Lili Chang Xinke Zhang Yongjun Liu Na Zhang 
This work was supported by a grant from the National Natural Science Foundation of China(Nos.81773652 and 81974498);the Young Scholar Program of Shandong University(2017WLJH40).
To improve therapeutic effect and reduce severely side effects of carboplatin(CBP),the gas-generating nanocapsules were developed to accelerate CBP lysosome release and nucleus delivery.CBP/SB-NC was prepared by co-lo...
关键词:CARBOPLATIN NANOCAPSULE pH-responsive release Gas-blasting Prostate cancer 
检索报告 对象比较 聚类工具 使用帮助 返回顶部